Cargando…

Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia

Background: Phosphoinositide 3-kinase inhibitors (PI3Ki) are a new class of medications used to treat HR positive, HER2 negative, PIK3CA mutated advanced or metastatic breast cancer. Inhibition of PI3K, a key enzyme in the insulin signaling pathway, leads to disruption of glucose metabolism and freq...

Descripción completa

Detalles Bibliográficos
Autores principales: Shey, Susan, Kim, Sarah, Kim, Julie, Murphy, Elizabeth J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089671/
http://dx.doi.org/10.1210/jendso/bvab048.803

Ejemplares similares